Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization

Journal of Virology

Volumn 89, Issue 5, 2015, Pages 2792-2800

  Ashour, Joseph ^a   Schmidt, Florian I ^a   Hanke, Leo ^a   Cragnolini, Juanjo ^a   Cavallari, Marco ^a   Altenburg, Arwen ^a   Brewer, Rebeccah ^a   Ingram, Jessica ^a   Shoemaker, Charles ^b   Ploegh, Hidde L ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS NUCLEOPROTEIN; VIRUS RNA; CORE PROTEIN; NANOBODY; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; ARTIODACTYLA; CELL MIGRATION; CONTROLLED STUDY; GENOME ANALYSIS; INFLUENZA VIRUS; LIFE CYCLE STAGE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; VIRUS GENOME; VIRUS IDENTIFICATION; ANIMAL; CELL LINE; CELL NUCLEUS; CHEMISTRY; DOG; GENE EXPRESSION; GENETICS; INFLUENZA A VIRUS; METABOLISM; MOLECULAR BIOLOGY; PHYSIOLOGY; PROCEDURES; VIROLOGY; VIRUS REPLICATION;

CAMELIDAE; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; RNA VIRUSES;

ANIMALS; CELL LINE; CELL NUCLEUS; DOGS; GENE EXPRESSION; INFLUENZA A VIRUS; MOLECULAR BIOLOGY; RNA-BINDING PROTEINS; SINGLE-DOMAIN ANTIBODIES; VIRAL CORE PROTEINS; VIROLOGY; VIRUS REPLICATION;

EID: 84922985301     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02693-14     Document Type: Article

References (59)

1. Gottschalk A, Fezekas De St Groth S. 1960. On the relationship between the indicator profile and prosthetic group of mucoproteins inhibitory for influenza virus haemagglutinin. J Gen Microbiol 22:690-697. http://dx.doi.org/10.1099/00221287-22-3-690.
2. Graham ER, Gottschalk A. 1960. Studies on mucoproteins. I. The structure of the prosthetic group of ovine submaxillary gland mucoprotein. Biochim Biophys Acta 38:513-524.
3. Hirst GK. 1948. The nature of the virus receptors of red cells; evidence on the chemical nature of the virus receptors of red cells and of the existence of a closely analogous substance in normal serum. J Exp Med 87:301-314. http://dx.doi.org/10.1084/jem.87.4.301.
4. Matlin KS, Reggio H, Helenius A, Simons K. 1981. Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91:601-613. http://dx.doi.org/10.1083/jcb.91.3.601.
5. Doms RW, Helenius A, White J. 1985. Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. J Biol Chem 260:2973-2981.
6. Martin K, Helenius A. 1991. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-130. http://dx.doi.org/10.1016/0092-8674(91)90576-K.
7. Ozawa M, Fujii K, Muramoto Y, Yamada S, Yamayoshi S, Takada A, Goto H, Horimoto T, Kawaoka Y. 2007. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 81:30-41. http://dx.doi.org/10.1128/JVI.01434-06.
8. Cros JF, Garcia-Sastre A, Palese P. 2005. An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic 6:205-213. http://dx.doi.org/10.1111/j.1600-0854.2005.00263.x.
9. Weber F, Kochs G, Gruber S, Haller O. 1998. A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology 250:9-18. http://dx.doi.org/10.1006/viro.1998.9329.
10. Neumann G, Castrucci MR, Kawaoka Y. 1997. Nuclear import and export of influenza virus nucleoprotein. J Virol 71:9690-9700.
11. O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J. 1995. Nuclear import of influenza virusRNAcan be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 270:22701-22704. http://dx.doi.org/10.1074/jbc.270.39.22701.
12. Huet S, Avilov SV, Ferbitz L, Daigle N, Cusack S, Ellenberg J. 2010. Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy. J Virol 84:1254-1264. http://dx.doi.org/10.1128/JVI.01533-09.
13. Tarendeau F, Boudet J, Guilligay D, Mas PJ, Bougault CM, Boulo S, Baudin F, Ruigrok RW, Daigle N, Ellenberg J, Cusack S, Simorre JP, Hart DJ. 2007. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat Struct Mol Biol 14:229-233. http://dx.doi.org/10.1038/nsmb1212.
14. Chou YY, Heaton NS, Gao Q, Palese P, Singer RH, Lionnet T. 2013. Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. PLoS Pathog 9:e1003358. http://dx.doi.org/10.1371/journal.ppat.1003358.
15. Biswas SK, Boutz PL, Nayak DP. 1998. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol 72:5493-5501.
16. Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D, Digard P. 2007. Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol 88:2280-2290. http://dx.doi.org/10.1099/vir.0.82809-0.
17. Elton D, Simpson-Holley M, Archer K, Medcalf L, Hallam R, McCauley J, Digard P. 2001. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol 75:408-419. http://dx.doi.org/10.1128/JVI.75.1.408-419.2001.
18. Digard P, Elton D, Bishop K, Medcalf E, Weeds A, Pope B. 1999. Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments. J Virol 73:2222-2231.
19. O'Neill RE, Palese P. 1995. NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology 206:116-125. http://dx.doi.org/10.1016/S0042-6822(95)80026-3.
20. Momose F, Basler CF, O'Neill RE, Iwamatsu A, Palese P, Nagata K. 2001. Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol 75:1899-1908. http://dx.doi.org/10.1128/JVI.75.4.1899-1908.2001.
21. Mackenzie JS, Dimmock NJ. 1973. A preliminary study of physiological characteristics of temperature-sensitive mutants of influenza virus. J Gen Virol 19:51-63. http://dx.doi.org/10.1099/0022-1317-19-1-51.
22. Palese P, Tobita K, Ueda M, Compans RW. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410. http://dx.doi.org/10.1016/0042-6822(74)90276-1.
23. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330. http://dx.doi.org/10.1006/viro.1998.9508.
24. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R. 1993. Naturally occurring antibodies devoid of light chains. Nature 363:446-448. http://dx.doi.org/10.1038/363446a0.
25. Holliger P, Hudson PJ. 2005. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126-1136. http://dx.doi.org/10.1038/nbt1142.
26. Cardoso FM, Ibanez LI, Van den Hoecke S, De Baets S, Smet A, Roose K, Schepens B, Descamps FJ, Fiers W, Muyldermans S, Depicker A, Saelens X. 2014. Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge. J Virol 88:8278-8296. http://dx.doi.org/10.1128/JVI.03178-13.
27. Ibanez LI, De Filette M, Hultberg A, Verrips T, Temperton N, Weiss RA, Vandevelde W, Schepens B, Vanlandschoot P, Saelens X. 2011. Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J Infect Dis 203:1063-1072. http://dx.doi.org/10.1093/infdis/jiq168.
28. Acharya P, Luongo TS, Georgiev IS, Matz J, Schmidt SD, Louder MK, Kessler P, Yang Y, McKee K, O'Dell S, Chen L, Baty D, Chames P, Martin L, Mascola JR, Kwong PD. 2013. Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor-and CD4-binding sites. J Virol 87:10173-10181. http://dx.doi.org/10.1128/JVI.01332-13.
29. Vercruysse T, Pardon E, Vanstreels E, Steyaert J, Daelemans D. 2010. An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production. J Biol Chem 285:21768-21780. http://dx.doi.org/10.1074/jbc.M110.112490.
30. Rothbauer U, Zolghadr K, Tillib S, Nowak D, Schermelleh L, Gahl A, Backmann N, Conrath K, Muyldermans S, Cardoso MC, Leonhardt H. 2006. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods 3:887-889. http://dx.doi.org/10.1038/nmeth953.
31. Kirchhofer A, Helma J, Schmidthals K, Frauer C, Cui S, Karcher A, Pellis M, Muyldermans S, Casas-Delucchi CS, Cardoso MC, Leonhardt H, Hopfner KP, Rothbauer U. 2010. Modulation of protein properties in living cells using nanobodies. Nat Struct Mol Biol 17:133-138. http://dx.doi.org/10.1038/nsmb.1727.
32. Caussinus E, Kanca O, Affolter M. 2012. Fluorescent fusion protein knockout mediated by anti-GFP nanobody. Nat Struct Mol Biol 19:117-121. http://dx.doi.org/10.1038/nsmb.2180.
33. Vanlandschoot P, Stortelers C, Beirnaert E, Ibanez LI, Schepens B, Depla E, Saelens X. 2011. Nanobodies(R): new ammunition to battle viruses. Antiviral Res 92:389-407. http://dx.doi.org/10.1016/j.antiviral.2011.09.002.
34. Avalos AM, Bilate AM, Witte MD, Tai AK, He J, Frushicheva MP, Thill PD, Meyer-Wentrup F, Theile CS, Chakraborty AK, Zhuang X, Ploegh HL. 2014. Monovalent engagement of the BCR activates ovalbuminspecific transnuclear B cells. J Exp Med 211:365-379. http://dx.doi.org/10.1084/jem.20131603.
35. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T, Schmitt EM, Bernardi RJ, Fu X, Bland CS, Cooper TA, Schiff R, Rosen JM, Westbrook TF, Elledge SJ. 2011. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 108:3665-3670. http://dx.doi.org/10.1073/pnas.1019736108.
36. Maass DR, Sepulveda J, Pernthaner A, Shoemaker CB. 2007. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs). J Immunol Methods 324:13-25. http://dx.doi.org/10.1016/j.jim.2007.04.008.
37. Popp MW, Karssemeijer RA, Ploegh HL. 2012. Chemoenzymatic sitespecific labeling of influenza glycoproteins as a tool to observe virus budding in real time. PLoS Pathog 8:e1002604. http://dx.doi.org/10.1371/journal.ppat.1002604.
38. Fleetwood F, Devoogdt N, Pellis M, Wernery U, Muyldermans S, Stahl S, Lofblom J. 2013. Surface display of a single-domain antibody library on Gram-positive bacteria. Cell Mol Life Sci 70:1081-1093. http://dx.doi.org/10.1007/s00018-012-1179-y.
39. Claessen JH, Mueller B, Spooner E, Pivorunas VL, Ploegh HL. 2010. The transmembrane segment of a tail-anchored protein determines its degradative fate through dislocation from the endoplasmic reticulum. J Biol Chem 285:20732-20739. http://dx.doi.org/10.1074/jbc.M110.120766.
40. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432-438. http://dx.doi.org/10.1038/384432a0.
41. Popp MW, Antos JM, Grotenbreg GM, Spooner E, Ploegh HL. 2007. Sortagging: a versatile method for protein labeling. Nat Chem Biol 3:707-708. http://dx.doi.org/10.1038/nchembio.2007.31.
42. Popp MW, Antos JM, Ploegh HL. 2009. Site-specific protein labeling via sortase-mediated transpeptidation. Curr Protoc Protein Sci Chapter 15: Unit 15.13. http://dx.doi.org/10.1002/0471140864.ps1503s56.
43. Witte MD, Cragnolini JJ, Dougan SK, Yoder NC, Popp MW, Ploegh HL. 2012. Preparation of unnatural N-to-N and C-to-C protein fusions. Proc Natl Acad Sci USA 109:11993-11998. http://dx.doi.org/10.1073/pnas.1205427109.
44. Dougan SK, Ashour J, Karssemeijer RA, Popp MW, Avalos AM, Barisa M, Altenburg AF, Ingram JR, Cragnolini JJ, Guo C, Alt FW, Jaenisch R, Ploegh HL. 2013. Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature 503:406-409. http://dx.doi.org/10.1038/nature12637.
45. Stojdl DF, Lichty BD, ten Oever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275. http://dx.doi.org/10.1016/S1535-6108(03)00241-1.
46. Watanabe T, Watanabe S, Kawaoka Y. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-439. http://dx.doi.org/10.1016/j.chom.2010.05.008.
47. Wu WW, Pante N. 2009. The directionality of the nuclear transport of the influenza A genome is driven by selective exposure of nuclear localization sequences on nucleoprotein. Virol J 6:68. http://dx.doi.org/10.1186/1743-422X-6-68.
48. Bullido R, Gomez-Puertas P, Albo C, Portela A. 2000. Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein. J Gen Virol 81:135-142.
49. Wu WW, Sun YH, Pante N. 2007. Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol J 4:49. http://dx.doi.org/10.1186/1743-422X-4-49.
50. Shimizu T, Takizawa N, Watanabe K, Nagata K, Kobayashi N. 2011. Crucial role of the influenza virus NS2 (NEP) C-terminal domain in M1 binding and nuclear export of vRNP. FEBS Lett 585:41-46. http://dx.doi.org/10.1016/j.febslet.2010.11.017.
51. Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, Chan MP, Chan CM, Wang P, Zheng BJ, Sun J, Huang JD, Madar J, Chen G, Chen H, Guan Y, Yuen KY. 2010. Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol 28:600-605. http://dx.doi.org/10.1038/nbt.1638.
52. Noton SL, Simpson-Holley M, Medcalf E, Wise HM, Hutchinson EC, McCauley JW, Digard P. 2009. Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions. J Virol 83:562-571. http://dx.doi.org/10.1128/JVI.01424-08.
53. Li Z, Watanabe T, Hatta M, Watanabe S, Nanbo A, Ozawa M, Kakugawa S, Shimojima M, Yamada S, Neumann G, Kawaoka Y. 2009. Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol 83:4153-4162. http://dx.doi.org/10.1128/JVI.02642-08.
54. Hagiwara K, Kondoh Y, Ueda A, Yamada K, Goto H, Watanabe T, Nakata T, Osada H, Aida Y. 2010. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-crosslinked chemical arrays. Biochem Biophys Res Commun 394:721-727. http://dx.doi.org/10.1016/j.bbrc.2010.03.058.
55. Shen YF, Chen YH, Chu SY, Lin MI, Hsu HT, Wu PY, Wu CJ, Liu HW, Lin FY, Lin G, Hsu PH, Yang AS, Cheng YS, Wu YT, Wong CH, Tsai MD. 2011. E339.R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors. Proc Natl Acad Sci USA 108:16515-16520. http://dx.doi.org/10.1073/pnas.1113107108.
56. Su CY, Cheng TJ, Lin MI, Wang SY, Huang WI, Lin-Chu SY, Chen YH, Wu CY, Lai MM, Cheng WC, Wu YT, Tsai MD, Cheng YS, Wong CH. 2010. High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci USA 107: 19151-19156. http://dx.doi.org/10.1073/pnas.1013592107.
57. Gerritz SW, Cianci C, Kim S, Pearce BC, Deminie C, Discotto L, McAuliffe B, Minassian BF, Shi S, Zhu S, Zhai W, Pendri A, Li G, Poss MA, Edavettal S, McDonnell PA, Lewis HA, Maskos K, Mortl M, Kiefersauer R, Steinbacher S, Baldwin ET, Metzler W, Bryson J, Healy MD, Philip T, Zoeckler M, Schartman R, Sinz M, Leyva-Grado VH, Hoffmann HH, Langley DR, Meanwell NA, Krystal M. 2011. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc Natl Acad Sci USA 108:15366-15371. http://dx.doi.org/10.1073/pnas.1107906108.
58. Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, Ruigrok RW, Di Primo C, Slama-Schwok A. 2013. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother 57:2231-2242. http://dx.doi.org/10.1128/AAC.02335-12.
59. Tereshko V, Uysal S, Koide A, Margalef K, Koide S, Kossiakoff AA. 2008. Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold. Protein Sci 17:1175-1187. http://dx.doi.org/10.1110/ps.034892.108.